121 related articles for article (PubMed ID: 10358454)
21. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
[TBL] [Abstract][Full Text] [Related]
22. Coexistence of struma ovarii with marked ascites and elevated CA-125 levels: case report and literature review.
Mui MP; Tam KF; Tam FK; Ngan HY
Arch Gynecol Obstet; 2009 May; 279(5):753-7. PubMed ID: 18807056
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic dilemma in an elderly woman with intractable ascites and elevated CA-125 level.
Gupta S; Maheshwari A; Wuntkal R; Mazid T; Tongaonkar HB
J Assoc Physicians India; 2006 Aug; 54():655-6. PubMed ID: 16941798
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.
Sthaneshwar P; Yap SF; Jayaram G
Malays J Pathol; 2002 Jun; 24(1):53-8. PubMed ID: 16329556
[TBL] [Abstract][Full Text] [Related]
25. Widespread endometriosis mimicking ovarian malignancy: a case report.
Akinola RA; Akinola OI; Alakija A; Wright KO
Niger Postgrad Med J; 2012 Mar; 19(1):46-9. PubMed ID: 22430602
[TBL] [Abstract][Full Text] [Related]
26. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
[TBL] [Abstract][Full Text] [Related]
28. A case of tuberculous peritonitis with elevated CA 125.
Cakir M; Dilber E; Yariş N; Mungan I; Okten A
Turk J Pediatr; 2005; 47(1):100-2. PubMed ID: 15884642
[No Abstract] [Full Text] [Related]
29. Peritoneal tuberculosis with elevated serum CA 125 level mimicking advanced ovarian carcinoma in an adolescent.
Corapçioğlu F; Güvenç BH; Sarper N; Aydoğan A; Akansel G; Arisoy ES
Turk J Pediatr; 2006; 48(1):69-72. PubMed ID: 16562790
[TBL] [Abstract][Full Text] [Related]
30. Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
Novakovic S; Fras PA; Jezersek-Novakovic B
In Vivo; 2001; 15(4):327-32. PubMed ID: 11695225
[TBL] [Abstract][Full Text] [Related]
31. [CA 125 in epithelial ovarian cancer].
Mogensen O
Ugeskr Laeger; 1998 May; 160(22):3236. PubMed ID: 9621807
[No Abstract] [Full Text] [Related]
32. [CA 125--a tumor marker?].
Pabst T; Ludwig C
Schweiz Med Wochenschr; 1995 Jun; 125(24):1195-200. PubMed ID: 7597408
[TBL] [Abstract][Full Text] [Related]
33. HLA-G is a potential tumor marker in malignant ascites.
Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker.
Chang WC; Hung YC; Kao CH; Yen RF; Shen YY; Lin CC
Neoplasma; 2002; 49(5):329-33. PubMed ID: 12458332
[TBL] [Abstract][Full Text] [Related]
35. [Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].
Jabłkowski M; Białkowska J; Koktysz R; Bartkowiak J; Stankiewicz W; Dworniak D
Pol Merkur Lekarski; 2004; 17 Suppl 1():149-52. PubMed ID: 15603376
[TBL] [Abstract][Full Text] [Related]
36. Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome.
Tjalma WA
Gynecol Oncol; 2005 Apr; 97(1):288-91. PubMed ID: 15790480
[TBL] [Abstract][Full Text] [Related]
37. [Epithelial ovarian cancer--preoperative assessment of Ca 125 levels as an independent prognostic factor].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2003; 42(3):16-9. PubMed ID: 12858485
[TBL] [Abstract][Full Text] [Related]
38. [Tumor marker in ovarian cancer].
Komai K; Nishida T
Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
[TBL] [Abstract][Full Text] [Related]
39. [Tumor markers and ovarian cysts].
Vinatier D; Houfflin V; Collinet P
J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S34-40. PubMed ID: 11917374
[TBL] [Abstract][Full Text] [Related]
40. Unique case of massive ascites, extreme elevation of serum CA 125 tumour marker.
Jotkowitz MW; Gee DC
Aust N Z J Obstet Gynaecol; 1993 Nov; 33(4):453-4. PubMed ID: 8179576
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
